Clemens Scherzer, M.D. is Professor of Neurology at Harvard Medical School. He directs the Center for Advanced Parkinson Research and the Precision Neurology Program of Brigham & Women’s Hospital. Scherzer uses genomes and computation to develop a future, predictive and proactive health care for Parkinson’s and other common neurologic diseases. His is to match precision drugs and biomarkers to the genetic blueprint of individual patients and prevent disease from ever progressing. Scherzer co-founded the major biobanks for Parkinson’s disease, including the Harvard Biomarkers Study. He serves on the Scientific Advisory Board of the American Parkinson Disease Foundation and his work was featured in Science, Scientific American, Washington Post, US News & World Reports, and NOVA Next.
Lead PI (Core Leadership)
Clemens Scherzer, MD
Brigham & Women's Hospital
Clemens Scherzer, M.D. is Professor of Neurology at Harvard Medical School. He directs the Center for Advanced Parkinson Research and the Precision Neurology Program of Brigham & Women’s Hospital. Scherzer uses genomes and computation to develop a future, predictive and proactive health care for Parkinson’s and other common neurologic diseases. His is to match precision drugs and biomarkers to the genetic blueprint of individual patients and prevent disease from ever progressing. Scherzer co-founded the major biobanks for Parkinson’s disease, including the Harvard Biomarkers Study. He serves on the Scientific Advisory Board of the American Parkinson Disease Foundation and his work was featured in Science, Scientific American, Washington Post, US News & World Reports, and NOVA Next.
